Skip to Main content
New interface

Researcher identifiers

Social networks

Number of documents

29

Sylvain Lamure


Practitioner in the clinical hematology department of the University Hospital of Montpellier, and doctoral student in biology and health at the Institute of Molecular Genetics of Montpellier, Hematopoiesis and Immunotherapy team. My research topics are: the impact of the use of professional pesticides on the occurrence and prognosis of hematological malignancies, CAR-T type modified T-cell therapies, donor lymphocyte injections, and the specificities of Covid-19 in the context of hematological malignancies.


Journal articles29 documents

  • Francesco Marchesi, Jon Salmanton-García, Ziad Emarah, Klára Piukovics, Marcio Nucci, et al.. COVID-19 in adult acute myeloid leukemia patients: a long-term followup study from the European Hematology Association survey (EPICOVIDEHA). Haematologica, Ferrata Storti Foundation, 2022, ⟨10.3324/haematol.2022.280847⟩. ⟨hal-03791177⟩
  • Marie-Kristin Tilch, Carlo Visco, Sandra Kinda, Olivier Hermine, Milena Kohn, et al.. Outcome of COVID-19 in Patients With Mantle Cell Lymphoma—Report From the European MCL Registry. HemaSphere, Lippincott, Williams & Wilkins, 2022, 6 (5), pp.e0711. ⟨10.1097/HS9.0000000000000711⟩. ⟨hal-03791222⟩
  • Marie Kristin Tilch, Carlo Visco, Sandra Bašić Kinda, Olivier Hermine, Milena Kohn, et al.. Outcome of COVID-19 in Patients with Mantle Cell Lymphoma—Report from the European MCL Registry. HemaSphere, Lippincott, Williams & Wilkins, 2022, 6 (5), ⟨10.1097/HS9.0000000000000711⟩. ⟨hal-03673380⟩
  • Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Alberto López-García, Sylvain Lamure, et al.. COVID-19 in vaccinated adult patients with hematological malignancies. Preliminary results from EPICOVIDEHA. Blood, American Society of Hematology, 2022, 139 (10), pp.1588-1592. ⟨10.1182/blood.2021014124⟩. ⟨hal-03791235⟩
  • Sylvain Lamure, Jon Salmanton-García, Elena Robin Marieton, Ozren Jaksic, Milena Kohn, et al.. COVID-19 and Hairy-Cell Leukemia: An EPICOVIDEHA Survey. Blood Advances, The American Society of Hematology, 2022, 6 (13), pp.3870-3874. ⟨10.1182/bloodadvances.2022007357⟩. ⟨hal-03690034⟩
  • Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Ola Blennow, Maria Gomes da Silva, et al.. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey. Blood, American Society of Hematology, 2022, ⟨10.1182/blood.2022017257/1922289/blood.2022017257.pdf⟩. ⟨hal-03791153⟩
  • Milena Kohn, Tamim Alsuliman, Sylvain Lamure, Morgane Cheminant, Jéremy Delage, et al.. Characteristics of SARS-CoV-2 infection in lymphoma/chronic lymphocytic leukemia patients during the Omicron outbreak. Leukemia & lymphoma, Taylor & Francis, 2022, pp.1-5. ⟨10.1080/10428194.2022.2086249⟩. ⟨hal-03791160⟩
  • Alessandro Busca, Jon Salmanton-García, Paolo Corradini, Francesco Marchesi, Alba Cabirta, et al.. COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP. Blood Advances, The American Society of Hematology, 2022, 6 (7), pp.2427-2433. ⟨10.1182/bloodadvances.2021005616⟩. ⟨hal-03645421⟩
  • Ola Blennow, Jon Salmanton-García, Piotr Nowak, Federico Itri, Jaap van Doesum, et al.. Outcome of infection with omicron SARS‐CoV ‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report. American Journal of Hematology, Wiley, 2022, 97 (8), ⟨10.1002/ajh.26626⟩. ⟨hal-03791162⟩
  • Thomas Hueso, Anne-Sophie Godron, Emilie Lanoy, Jérôme Pacanowski, Laura Levi, et al.. Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis. Leukemia, 2022, 36 (4), pp.1025-1034. ⟨10.1038/s41375-022-01511-6⟩. ⟨hal-03642648⟩
  • Alessandro Busca, Jon Salmanton-García, Paolo Corradini, Francesco Marchesi, Alba Cabirta, et al.. COVID-19 and CAR-T cells: current challenges and future directions-a report from the EPICOVIDEHA survey by EHA-IDWP. Blood Advances, The American Society of Hematology, 2021, ⟨10.1182/bloodadvances.2021005616/1833925/bloodadvances.2021005616.pdf⟩. ⟨hal-03430350⟩
  • Radjiv Goulabchand, Nicolas Malafaye, William Jacot, Philine Witkowski Durand Viel, Jacques Morel, et al.. Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database. Autoimmunity Reviews, Elsevier, 2021, 20 (12), pp.102987. ⟨10.1016/j.autrev.2021.102987⟩. ⟨hal-03622565⟩
  • Sylvain Lamure, François van Laethem, Delphine de Verbizier, Claire Lozano, Eve Gehlkopf, et al.. Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy. Cancers, MDPI, 2021, 13 (17), pp.4279. ⟨10.3390/cancers13174279⟩. ⟨hal-03327590⟩
  • Megane Giraud, Pascal Cathébras, X. Roblin, Damien Thibaudin, Sylvain Lamure, et al.. Immunomonitoring du rituximab appliqué aux maladies auto-immunes : une aide pour la pratique clinique ?. La Revue de Médecine Interne, Elsevier, 2021, 42 (6), pp.384-391. ⟨10.1016/j.revmed.2021.02.006⟩. ⟨hal-03203418⟩
  • Léa Fornero, Sylvain Lamure. Nouvelle AMM : duvelisib – LLC et lymphome folliculaire en rechute ou réfractaire. Bulletin du Cancer, John Libbey Eurotext, 2021, 108 (10), pp.906-907. ⟨10.1016/j.bulcan.2021.06.010⟩. ⟨hal-03791143⟩
  • Rémy Duléry, Sylvain Lamure, Marc Delord, Roberta Di Blasi, Adrien Chauchet, et al.. Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy. American Journal of Hematology, 2021, 96 (8), pp.934-944. ⟨10.1002/ajh.26209⟩. ⟨hal-03401859⟩
  • Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Alessandro Busca, Paolo Corradini, et al.. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). Journal of Hematology and Oncology, BioMed Central, 2021, 14 (1), pp.168. ⟨10.1186/s13045-021-01177-0⟩. ⟨hal-03642030⟩
  • Sylvain Lamure. Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B‐cell lymphoma, a clinico‐pathological series of 25 cases. British Journal of Haematology, Wiley, 2020, ⟨10.1111/bjh.16331⟩. ⟨hal-03791262⟩
  • Catherine Belin, Perrine Devic, Xavier Ayrignac, Amélie dos Santos, Adrien Paix, et al.. Description of neurotoxicity in a series of patients treated with CAR T-cell therapy. Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.91-93. ⟨10.1038/s41598-020-76055-9⟩. ⟨hal-03203401⟩
  • Guillaume Aussedat, Alexandra Traverse‐glehen, Aspasia Stamatoullas, Thierry Molina, Violaine Safar, et al.. Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B‐cell lymphoma, a clinico‐pathological series of 25 cases. British Journal of Haematology, Wiley, 2020, 189 (2), pp.244-256. ⟨10.1111/bjh.16331⟩. ⟨hal-02872482⟩
  • Sylvain Lamure, Franciane Paul, Anne-Laure Gagez, Jérémy Delage, Laure Vincent, et al.. A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment. Journal of Clinical Medicine, MDPI, 2020, 9 (7), pp.2204. ⟨10.3390/jcm9072204⟩. ⟨hal-03203259⟩
  • Orianne Villard, David Morquin, Nicolas Molinari, Isabelle Raingeard, Nicolas Nagot, et al.. The Plasmatic Aldosterone and C-Reactive Protein Levels, and the Severity of Covid-19: The Dyhor-19 Study. Journal of Clinical Medicine, MDPI, 2020, 9 (7), pp.2315. ⟨10.3390/jcm9072315⟩. ⟨hal-02906692⟩
  • Sylvain Lamure, Rémy Duléry, Roberta Di Blasi, Adrien Chauchet, Cécile Laureana, et al.. Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study. EClinicalMedicine, Elsevier, 2020, 27, pp.100549. ⟨10.1016/j.eclinm.2020.100549⟩. ⟨hal-03203358⟩
  • John de Vos, Etienne Baudoux, Jacques-Olivier Bay, Boris Calmels, Audrey Cras, et al.. Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (1), pp.S35-S39. ⟨hal-02055937⟩
  • John de Vos, Etienne Baudoux, Jacques-Olivier Bay, Boris Calmels, Audrey Cras, et al.. Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (1), pp.S35-S39. ⟨10.1016/j.bulcan.2018.10.002⟩. ⟨hal-02650987⟩
  • Sylvain Lamure, Camille Carles, Quam Aquereburu, Philippe Quittet, Emmanuelle Tchernonog, et al.. Association of Occupational Pesticide Exposure With Immunochemotherapy Response and Survival Among Patients With Diffuse Large B-Cell Lymphoma. JAMA Network Open, American Medical Association, 2019, 2 (4), pp.e192093. ⟨10.1001/jamanetworkopen.2019.2093⟩. ⟨hal-02863305⟩
  • Claire Gourzones, Céline Bellanger, Sylvain Lamure, Ouissem Karmous Gadacha, Elvira Garcia de Paco, et al.. Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells. Cancers, 2019, 11 (4), pp.439. ⟨10.3390/cancers11040439⟩. ⟨hal-02870153⟩
  • S. Lamure, J. Delage, L. Vincent, N. Fegueux, L. Zhao-Yang, et al.. Infusion of in vivo expanded cord blood lymphocytes: A new strategy to control residual disease?. Current Research in Translational Medicine, Elsevier-Masson SAS, 2018, 66 (3), pp.91-93. ⟨10.1016/j.retram.2018.02.003⟩. ⟨hal-03122708⟩
  • Sylvain Lamure, P. Latry, T. Kanouni, Y. Hicheri, L Vincent, et al.. Transfusion thérapeutique de granulocytes : cinétique et aspects organisationnels autour d’un cas clinique. Transfusion Clinique et Biologique, Elsevier, 2014, 21 (6), pp.324 - 327. ⟨10.1016/j.tracli.2014.09.005⟩. ⟨hal-03203379⟩